Sex differences in endothelial function markers before conversion to pre-diabetes: Does the clock start ticking earlier among women? The Western New York Study

Diabetes Care

Volumn 30, Issue 2, 2007, Pages 354-359

  Donahue, Richard P ^a   Rejman, Karol ^a   Rafalson, Lisa B ^a   Dmochowski, Jacek ^a,b   Stranges, Saverio ^a   Trevisan, Maurizio ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SEX DIFFERENCE; THROMBOSIS;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; NEW YORK; PREDIABETIC STATE; RISK FACTORS; SEX CHARACTERISTICS; THROMBOSIS; TIME FACTORS;

EID: 33846663253     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1772     Document Type: Article

References (43)

1. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297, 1999
2. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339:861-867, 1998
3. Pearate CA, Furberg C, O'Meara ES, Psaty BM, Kuller LH, Rowe NR, Manolio T: Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease in adults: the Cardiovascular Health Study. Circulation 113:2177-2185, 2006
4. Becker RC, Terrin M, Ross R, Knatterud GL, Sesvigne-Nickens P, Gore JM, Braunwald E, the Thrombolysis in Myocardial Infarction Investigators: Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann Intern Med 120:638-645, 1994
5. Hanratty B, Lawlor DA, Robinson MB, Sapsford FR, Greenwood D, Hall A: Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. J Epidemiol Community Health 54:912-926, 2000
6. Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM, the National Registry of Myocardial Infarction Investigators: Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 353:671-682, 2005
7. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant GB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, the WISE Investigators: Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I. Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47 (Suppl. A):4A-20A, 2006
8. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, the WISE Investigators: Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part II. Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis, macro-, and microvascular disease. J Am Coll Cardiol 47 (Suppl. A):21A-29A, 2006
9. Orchard TJ: The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin dependent diabetes mellitus. Ann Med 28:323-333, 1996
10. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications: an epidemiologic perspective. Diabetes Care 15:1141-1155, 1992
11. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129-1134, 2002
12. Haffner SM, Miettinen H, Stern MP: Relatively more atherogenic coronary heart disease risk factors in prediabetic women than prediabetic men. Diabetologia 40:711-717, 1997
13. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
14. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
15. Kuller LH, Tracy RP, Shaten J, Meilahn EN: Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am J Epidemiol 144:537-547, 1996
16. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
17. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353:1649-1652, 1999
18. Meigs JB, Hu FB, Rifai N, Manson JI: Biomarkers of endothelial function and risk of type 2 diabetes mellitus. JAMA 291:1978-1986, 2004
19. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
20. Matsuhita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H: Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 26:871-876, 2006
21. Shulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB: Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54:534-539, 2005
22. Pishon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737, 2004
23. Stranges S, Wu T, Dorn JM, Freudenheim JL, Mutie P, Farinaro E, Russell M, Nochajski TH, Trevisan M: Relationship of alcohol drinking pattern to the risk of hypertension: a population-based study. Hypertension 44:813-819, 2004
24. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP: Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension 46:1-8, 2005
25. Chobanian AV, Bakrisk GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Matersn BJ, Oparil S, Wright JT Jr, Roccella EJ, the National Heart Lung and Blood Institute Joint National Committee on Prevention, National High blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572, 2003
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function form fasting glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
27. Bakker AJ: Detection of microalbuminuria: receiver operating curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22:307-313, 1999
28. Neter J, Wasserman W: Applied Linear Statistical Models: Regression, Analysis of Variance and Experimental Design. Homewood, IL, Richard D. Irvin, 1974
29. Carroll RJ, Wang S, Wang CY: Prospective analysis of logistic case-control studies. JASA 90:157-169, 1995
30. D'Agostino RB, Hamman RF, Karater AJ, Mykkaned L, Wagenknecht LE, Haffner SM, the Insulin Resistance Atherosclerosis Study Investigators: Cardiovascular disease risk factors predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27:2234-2240, 2004
31. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
32. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Llanne-Parikka P, Keinanen-Kiukaanniem S, Laakso M, Louheranta A, Rastas M, Salminen V, Uustiupa M, the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
33. Orchard TJ, Becker DJ, Kuller LH, Wagener DK, LaPorte RE: Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk. J Chronic Dis 35:123-132, 1982
34. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acutephase reactants and interleukin 6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1977
35. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, Rattigan S: Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol 284:E241-E258, 2003
36. Anderson RL, Hamman RF, Savage PJ, Saad MF, Laws A, Kades WW, Sands RE, Cefalu W, the Insulin Resistance Atherosclerosis Study: Exploration of simple insulin sensitivity measures derived from frequency samples intravenous glucose tolerance (FSIGT) tests. Am J Epidemiol 142:724-732, 1995
37. Caballero AE, Arora S, Rola S, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FL, Horton ES, Veves A: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856-1862, 1999
38. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, Klein BEK, Hubbard LD: Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis in Communities study. JAMA 287:1153-1159, 2002
39. Klein R, Sharrett AE, Klein BED, Chambless LE, Cooper LS, Hubbard LD, Evans G: Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol 20:1641-1650, 2000
40. Pinkney JH, Sehouwer CDA, Coppack SW, Yudkin JS: Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46 (Suppl. 2):S9-S13, 1997
41. Aggawal B, Puri R: Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA, Blackwell Science, 1995
42. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219-226, 1989
43. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 21:1686-1690, 1998